APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pleural Effusions Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pleural Effusions Treatment Industry Growth and Trends Forecast to 2032

19 December 2025104 pages

Choose your research edition.

Industry ResearchPleural Effusions Treatment Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pleural Effusions Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pleural Effusions Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pleural Effusions Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pleural Effusions Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Pleural Effusions Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pleural Effusions Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pleural Effusions Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pleural Effusions Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pleural Effusions Treatment market include Shyndec Pharmaceutical, Lepu Medical, B. Braun, Balance Medical, Smith Medical, Redax, Oakworks Medical, Nouvag and Maxer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pleural Effusions Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pleural Effusions Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pleural Effusions Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pleural Effusions Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pleural Effusions Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pleural Effusions Treatment Market by Company

Shyndec Pharmaceutical

Lepu Medical

B. Braun

Balance Medical

Smith Medical

Redax

Oakworks Medical

Nouvag

Maxer

Heyer Medical

Grena

Biometrix

Bicakcilar

Pleural Effusions Treatment Segment by Type

Thoracentesis

Pleurodesis

Pleuroperitoneal Shunt

Pleural Effusions Treatment Segment by Application

Hospitals

Clinics

Others

Pleural Effusions Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pleural Effusions Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pleural Effusions Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pleural Effusions Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pleural Effusions Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pleural Effusions Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pleural Effusions Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pleural Effusions Treatment Market Share by Region (2021-2026) Table 4. Global Pleural Effusions Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pleural Effusions Treatment Market Share by Region (2027-2032) Table 6. Global Pleural Effusions Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pleural Effusions Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pleural Effusions Treatment Market Size Share by Type (2021-2026) Table 9. Global Pleural Effusions Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pleural Effusions Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pleural Effusions Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pleural Effusions Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pleural Effusions Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pleural Effusions Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pleural Effusions Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pleural Effusions Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pleural Effusions Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pleural Effusions Treatment Market Size Share by Application (2021-2026) Table 24. Global Pleural Effusions Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pleural Effusions Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pleural Effusions Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pleural Effusions Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pleural Effusions Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pleural Effusions Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pleural Effusions Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pleural Effusions Treatment Industry Trends Table 37. Pleural Effusions Treatment Industry Drivers Table 38. Pleural Effusions Treatment Industry Opportunities and Challenges Table 39. Pleural Effusions Treatment Industry Restraints Table 40. Global Pleural Effusions Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pleural Effusions Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Pleural Effusions Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pleural Effusions Treatment Key Company Headquarters & Area Served Table 44. Global Pleural Effusions Treatment Company, Product Type & Application Table 45. Global Pleural Effusions Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pleural Effusions Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Shyndec Pharmaceutical Company Information Table 49. Shyndec Pharmaceutical Business Overview Table 50. Shyndec Pharmaceutical Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Shyndec Pharmaceutical Pleural Effusions Treatment Product Portfolio Table 52. Shyndec Pharmaceutical Recent Development Table 53. Lepu Medical Company Information Table 54. Lepu Medical Business Overview Table 55. Lepu Medical Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lepu Medical Pleural Effusions Treatment Product Portfolio Table 57. Lepu Medical Recent Development Table 58. B. Braun Company Information Table 59. B. Braun Business Overview Table 60. B. Braun Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. B. Braun Pleural Effusions Treatment Product Portfolio Table 62. B. Braun Recent Development Table 63. Balance Medical Company Information Table 64. Balance Medical Business Overview Table 65. Balance Medical Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Balance Medical Pleural Effusions Treatment Product Portfolio Table 67. Balance Medical Recent Development Table 68. Smith Medical Company Information Table 69. Smith Medical Business Overview Table 70. Smith Medical Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Smith Medical Pleural Effusions Treatment Product Portfolio Table 72. Smith Medical Recent Development Table 73. Redax Company Information Table 74. Redax Business Overview Table 75. Redax Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Redax Pleural Effusions Treatment Product Portfolio Table 77. Redax Recent Development Table 78. Oakworks Medical Company Information Table 79. Oakworks Medical Business Overview Table 80. Oakworks Medical Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Oakworks Medical Pleural Effusions Treatment Product Portfolio Table 82. Oakworks Medical Recent Development Table 83. Nouvag Company Information Table 84. Nouvag Business Overview Table 85. Nouvag Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nouvag Pleural Effusions Treatment Product Portfolio Table 87. Nouvag Recent Development Table 88. Maxer Company Information Table 89. Maxer Business Overview Table 90. Maxer Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Maxer Pleural Effusions Treatment Product Portfolio Table 92. Maxer Recent Development Table 93. Heyer Medical Company Information Table 94. Heyer Medical Business Overview Table 95. Heyer Medical Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Heyer Medical Pleural Effusions Treatment Product Portfolio Table 97. Heyer Medical Recent Development Table 98. Grena Company Information Table 99. Grena Business Overview Table 100. Grena Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Grena Pleural Effusions Treatment Product Portfolio Table 102. Grena Recent Development Table 103. Biometrix Company Information Table 104. Biometrix Business Overview Table 105. Biometrix Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Biometrix Pleural Effusions Treatment Product Portfolio Table 107. Biometrix Recent Development Table 108. Bicakcilar Company Information Table 109. Bicakcilar Business Overview Table 110. Bicakcilar Pleural Effusions Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bicakcilar Pleural Effusions Treatment Product Portfolio Table 112. Bicakcilar Recent Development Table 113. North America Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Pleural Effusions Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Pleural Effusions Treatment Market Share by Country (2021-2026) Table 116. North America Pleural Effusions Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Pleural Effusions Treatment Market Share Forecast by Country (2027-2032) Table 118. Europe Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Pleural Effusions Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Pleural Effusions Treatment Market Share by Country (2021-2026) Table 121. Europe Pleural Effusions Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Pleural Effusions Treatment Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Pleural Effusions Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Pleural Effusions Treatment Market Share by Country (2021-2026) Table 126. Asia-Pacific Pleural Effusions Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Pleural Effusions Treatment Market Share Forecast by Country (2027-2032) Table 128. Latin America Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Pleural Effusions Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Pleural Effusions Treatment Market Share by Country (2021-2026) Table 131. Latin America Pleural Effusions Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Pleural Effusions Treatment Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Pleural Effusions Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Pleural Effusions Treatment Market Share by Country (2021-2026) Table 136. Middle East & Africa Pleural Effusions Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Pleural Effusions Treatment Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pleural Effusions Treatment Product Image Figure 3. Global Pleural Effusions Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pleural Effusions Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Pleural Effusions Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Pleural Effusions Treatment Market Share by Region (2021-2032) Figure 7. North America Pleural Effusions Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pleural Effusions Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pleural Effusions Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pleural Effusions Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pleural Effusions Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Thoracentesis Image Figure 13. Global Thoracentesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pleurodesis Image Figure 15. Global Pleurodesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Pleuroperitoneal Shunt Image Figure 17. Global Pleuroperitoneal Shunt Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Pleural Effusions Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Pleural Effusions Treatment Market Share by Type 2025 VS 2032 Figure 20. North America Pleural Effusions Treatment Market Size Share by Type (2021-2032) Figure 21. Europe Pleural Effusions Treatment Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Pleural Effusions Treatment Market Size Share by Type (2021-2032) Figure 23. Latin America Pleural Effusions Treatment Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Pleural Effusions Treatment Market Size Share by Type (2021-2032) Figure 25. Hospitals Image Figure 26. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinics Image Figure 28. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Pleural Effusions Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pleural Effusions Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Pleural Effusions Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Pleural Effusions Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Pleural Effusions Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Pleural Effusions Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Pleural Effusions Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Pleural Effusions Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Pleural Effusions Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Pleural Effusions Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Pleural Effusions Treatment Market Share by Country (2021-2032) Figure 43. Europe Pleural Effusions Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Pleural Effusions Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pleural Effusions Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Pleural Effusions Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Pleural Effusions Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Pleural Effusions Treatment Market Share by Country (2021-2032) Figure 49. Latin America Pleural Effusions Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Pleural Effusions Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Pleural Effusions Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Pleural Effusions Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Pleural Effusions Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Pleural Effusions Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Thoracentesis
  • Pleurodesis
  • Pleuroperitoneal Shunt
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Shyndec Pharmaceutical
  • Lepu Medical
  • B. Braun
  • Balance Medical
  • Smith Medical
  • Redax
  • Oakworks Medical
  • Nouvag
  • Maxer
  • Heyer Medical
  • Grena
  • Biometrix
  • Bicakcilar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pleural Effusions Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pleural Effusions Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Pleural Effusions Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Pleural Effusions Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pleural Effusions Treatment Market Size (2021-2032)
  8. 1.5.1 North America Pleural Effusions Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pleural Effusions Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pleural Effusions Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pleural Effusions Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pleural Effusions Treatment Market Size Growth Rate (2021-2032)
2 Pleural Effusions Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Thoracentesis
  3. 2.1.2 Pleurodesis
  4. 2.1.3 Pleuroperitoneal Shunt
  5. 2.2 Global Pleural Effusions Treatment Market Size by Type
  6. 2.2.1 Global Pleural Effusions Treatment Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Pleural Effusions Treatment Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Pleural Effusions Treatment Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Pleural Effusions Treatment Market Size by Regions
  10. 2.3.1 North America Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Pleural Effusions Treatment Market Size Breakdown by Type (2021-2026)
3 Pleural Effusions Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.1.3 Others
  5. 3.2 Global Pleural Effusions Treatment Market Size by Application
  6. 3.2.1 Global Pleural Effusions Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Pleural Effusions Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Pleural Effusions Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Pleural Effusions Treatment Market Size by Regions
  10. 3.3.1 North America Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Pleural Effusions Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pleural Effusions Treatment Industry Trends
  2. 4.2 Pleural Effusions Treatment Industry Drivers
  3. 4.3 Pleural Effusions Treatment Industry Opportunities and Challenges
  4. 4.4 Pleural Effusions Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pleural Effusions Treatment Revenue (2021-2026)
  2. 5.2 Global Pleural Effusions Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pleural Effusions Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Pleural Effusions Treatment Company, Product Type & Application
  5. 5.5 Global Pleural Effusions Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pleural Effusions Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pleural Effusions Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pleural Effusions Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Shyndec Pharmaceutical
  2. 6.1.1 Shyndec Pharmaceutical Company Information
  3. 6.1.2 Shyndec Pharmaceutical Business Overview
  4. 6.1.3 Shyndec Pharmaceutical Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Shyndec Pharmaceutical Pleural Effusions Treatment Product Portfolio
  6. 6.1.5 Shyndec Pharmaceutical Recent Developments
  7. 6.2 Lepu Medical
  8. 6.2.1 Lepu Medical Company Information
  9. 6.2.2 Lepu Medical Business Overview
  10. 6.2.3 Lepu Medical Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lepu Medical Pleural Effusions Treatment Product Portfolio
  12. 6.2.5 Lepu Medical Recent Developments
  13. 6.3 B. Braun
  14. 6.3.1 B. Braun Company Information
  15. 6.3.2 B. Braun Business Overview
  16. 6.3.3 B. Braun Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 B. Braun Pleural Effusions Treatment Product Portfolio
  18. 6.3.5 B. Braun Recent Developments
  19. 6.4 Balance Medical
  20. 6.4.1 Balance Medical Company Information
  21. 6.4.2 Balance Medical Business Overview
  22. 6.4.3 Balance Medical Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Balance Medical Pleural Effusions Treatment Product Portfolio
  24. 6.4.5 Balance Medical Recent Developments
  25. 6.5 Smith Medical
  26. 6.5.1 Smith Medical Company Information
  27. 6.5.2 Smith Medical Business Overview
  28. 6.5.3 Smith Medical Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Smith Medical Pleural Effusions Treatment Product Portfolio
  30. 6.5.5 Smith Medical Recent Developments
  31. 6.6 Redax
  32. 6.6.1 Redax Company Information
  33. 6.6.2 Redax Business Overview
  34. 6.6.3 Redax Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Redax Pleural Effusions Treatment Product Portfolio
  36. 6.6.5 Redax Recent Developments
  37. 6.7 Oakworks Medical
  38. 6.7.1 Oakworks Medical Company Information
  39. 6.7.2 Oakworks Medical Business Overview
  40. 6.7.3 Oakworks Medical Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Oakworks Medical Pleural Effusions Treatment Product Portfolio
  42. 6.7.5 Oakworks Medical Recent Developments
  43. 6.8 Nouvag
  44. 6.8.1 Nouvag Company Information
  45. 6.8.2 Nouvag Business Overview
  46. 6.8.3 Nouvag Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nouvag Pleural Effusions Treatment Product Portfolio
  48. 6.8.5 Nouvag Recent Developments
  49. 6.9 Maxer
  50. 6.9.1 Maxer Company Information
  51. 6.9.2 Maxer Business Overview
  52. 6.9.3 Maxer Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Maxer Pleural Effusions Treatment Product Portfolio
  54. 6.9.5 Maxer Recent Developments
  55. 6.10 Heyer Medical
  56. 6.10.1 Heyer Medical Company Information
  57. 6.10.2 Heyer Medical Business Overview
  58. 6.10.3 Heyer Medical Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Heyer Medical Pleural Effusions Treatment Product Portfolio
  60. 6.10.5 Heyer Medical Recent Developments
  61. 6.11 Grena
  62. 6.11.1 Grena Company Information
  63. 6.11.2 Grena Business Overview
  64. 6.11.3 Grena Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Grena Pleural Effusions Treatment Product Portfolio
  66. 6.11.5 Grena Recent Developments
  67. 6.12 Biometrix
  68. 6.12.1 Biometrix Company Information
  69. 6.12.2 Biometrix Business Overview
  70. 6.12.3 Biometrix Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Biometrix Pleural Effusions Treatment Product Portfolio
  72. 6.12.5 Biometrix Recent Developments
  73. 6.13 Bicakcilar
  74. 6.13.1 Bicakcilar Company Information
  75. 6.13.2 Bicakcilar Business Overview
  76. 6.13.3 Bicakcilar Pleural Effusions Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bicakcilar Pleural Effusions Treatment Product Portfolio
  78. 6.13.5 Bicakcilar Recent Developments
7 North America
  1. 7.1 North America Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pleural Effusions Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Pleural Effusions Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pleural Effusions Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Pleural Effusions Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pleural Effusions Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pleural Effusions Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pleural Effusions Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Pleural Effusions Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pleural Effusions Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pleural Effusions Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pleural Effusions Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst